Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.420
+0.100 (7.58%)
At close: Feb 6, 2026, 4:00 PM EST
1.408
-0.012 (-0.82%)
After-hours: Feb 6, 2026, 7:59 PM EST
Autolus Therapeutics Market Cap
Autolus Therapeutics has a market cap or net worth of $377.92 million as of February 6, 2026. Its market cap has decreased by -37.99% in one year.
Market Cap
377.92M
Enterprise Value
335.69M
1-Year Change
-37.99%
Ranking
Category
Stock Price
$1.42
Market Cap Chart
Since June 22, 2018, Autolus Therapeutics's market cap has decreased from $969.66M to $377.92M, a decrease of -61.02%. That is a compound annual growth rate of -11.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 377.92M | -28.64% |
| Dec 31, 2025 | 529.63M | -15.31% |
| Dec 31, 2024 | 625.39M | -44.17% |
| Dec 29, 2023 | 1.12B | 240.67% |
| Dec 30, 2022 | 328.81M | -13.12% |
| Dec 31, 2021 | 378.45M | -19.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adlai Nortye | 374.17M |
| Bicycle Therapeutics | 368.34M |
| Aclaris Therapeutics | 367.29M |
| Allogene Therapeutics | 366.31M |
| Entrada Therapeutics | 360.41M |
| Greenwich LifeSciences | 349.00M |
| Protara Therapeutics | 348.32M |
| Puma Biotechnology | 342.16M |